INDEPENDENT CITIZENS OVERSIGHT COMMITTEE (“ICOC”)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To Government Code section 11346.5(a)(17)
and
The CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Open Session

1. Call to Order.
2. Pledge of Allegiance.
3. Roll Call.

   [Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

CONSENT ITEMS

4. Approval of minutes from March 12th, 2008 ICOC Meeting.

EXECUTIVE PRESENTATIONS

5. Chairman’s Report.
6. President’s Report.

ACTION ITEMS

7. Consideration of telephonic peer review called on short notice for urgent and/or opportune research opportunities.
8. Consideration of new scientific members for the Grants Working Group.
9. Consideration of concept plan for Training Grants II Program.
10. Consideration of concept plan for Technical Training Awards.
11. Consideration of final adoption of Grants Administration Policy for For-Profit Organizations.
        a. Regulation
12. Consideration of update from Loan Task Force.
13. Consideration of amendments to CIRM Interim Grant Administration Policy for Major Facilities Grants.
14. Consideration of recommendations from Facilities Working Group and Grants Working Group on Major Facilities applications.
        b. Draft terms of discount offer

   15.
           a. Discussion of confidential intellectual property or work product and prepublication, confidential scientific
               research or data relating to Major Facilities applications. (Health & Safety Code 125290.30(d) (3) (B) and
               (C)).
           b. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section
               125290.30(d) (3) (D)).
           c. Pending Litigation (Government Code section 11126, subdivision (e)): Mary Scott Doe v. Robert Klein, et al.

Open Session

16. Public report of any action taken, if necessary, during closed session.
17. Consideration of definition of “California Supplier.”
18. Consideration of equipment funding for Major Facilities program.
19. Consideration of recommendations from ICOC subcommittee regarding definitions and requirements for CIRM RFAs including, but not limited to, definition of PI, minimum required effort by PIs and number of application submissions per institution.

DISCUSSION ITEMS

20. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.